Diabetes hinders community-acquired pneumonia outcomes in hospitalized patients

被引:43
|
作者
Martins, M. [1 ,2 ,3 ]
Boavida, J. M. [1 ]
Raposo, J. F. [1 ,2 ]
Froes, F. [4 ]
Nunes, B. [5 ]
Ribeiro, R. T. [1 ,2 ]
Macedo, M. P. [1 ,2 ]
Penha-Goncalves, C. [3 ]
机构
[1] APDP Diabet Portugal Educ & Res Ctr ERC, Lisbon, Portugal
[2] Univ Nova Lisboa, NOVA Med Sch FCM, Chron Dis Res Ctr CEDOC, Lisbon, Portugal
[3] Inst Gulbenkian Ciencias, Oeiras, Portugal
[4] Ctr Hosp Lisboa Norte, Hosp Pulido Valente, Serv Pneumol, Lisbon, Portugal
[5] Inst Nacl Saude Dr Ricardo Jorge, Dept Epidemiol, Lisbon, Portugal
关键词
INFECTIOUS-DISEASES; RISK; MELLITUS; PEOPLE; ADMISSIONS; MANAGEMENT; PORTUGAL; COSTS;
D O I
10.1136/bmjdrc-2015-000181
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: This study aimed to estimate the prevalence of diabetes mellitus (DM) in hospitalized patients with community-acquired pneumonia (CAP) and its impact on hospital length of stay and in-hospital mortality. Research design and methods: We carried out a retrospective, nationwide register analysis of CAP in adult patients admitted to Portuguese hospitals between 2009 and 2012. Anonymous data from 157 291 adult patients with CAP were extracted from the National Hospital Discharge Database and we performed a DM-conditioned analysis stratified by age, sex and year of hospitalization. Results: The 74 175 CAP episodes that matched the inclusion criteria showed a high burden of DM that tended to increase over time, from 23.7% in 2009 to 28.1% in 2012. Interestingly, patients with CAP had high DM prevalence in the context of the national DM prevalence. Episodes of CAP in patients with DM had on average 0.8 days longer hospital stay as compared to patients without DM (p<0.0001), totaling a surplus of 15 370 days of stay attributable to DM in 19 212 admissions. In-hospital mortality was also significantly higher in patients with CAP who have DM (15.2%) versus those who have DM (13.5%) (p=0.002). Conclusions: Our analysis revealed that DM prevalence was significantly increased within CAP hospital admissions, reinforcing other studies' findings that suggest that DM is a risk factor for CAP. Since patients with CAP who have DM have longer hospitalization time and higher mortality rates, these results hold informative value for patient guidance and healthcare strategies.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Ampicillin/sulbactam for children hospitalized with community-acquired pneumonia
    Tapisiz, Anil
    Ozdemir, Halil
    Ciftci, Ergin
    Belet, Nursen
    Ince, Erdal
    Dogru, Ulker
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2011, 17 (04) : 504 - 509
  • [32] Adjunct Corticosteroids in Children Hospitalized With Community-Acquired Pneumonia
    Weiss, Anna K.
    Hall, Matthew
    Lee, Grace E.
    Kronman, Matthew P.
    Sheffler-Collins, Seth
    Shah, Samir S.
    PEDIATRICS, 2011, 127 (02) : E255 - E263
  • [33] Association Between Time to Clinical Stability and Outcomes After Discharge in Hospitalized Patients With Community-Acquired Pneumonia
    Aliberti, Stefano
    Peyrani, Paula
    Filardo, Giovanni
    Mirsaeidi, Mehdi
    Amir, Asad
    Blasi, Francesco
    Ramirez, Julio A.
    CHEST, 2011, 140 (02) : 482 - 488
  • [34] Prospective Comparison of Severity Scores for Predicting Clinically Relevant Outcomes for Patients Hospitalized With Community-Acquired Pneumonia
    Espana Yandiola, Pedro Pablo
    Capelastegui, Alberto
    Quintana, Jose
    Diez, Rosa
    Gorodo, Inmaculada
    Bilbao, Amaia
    Zalacain, Rafael
    Menendez, Rosario
    Torres, Antonio
    CHEST, 2009, 135 (06) : 1572 - 1579
  • [35] Therapeutic efficacy of moxifloxacin in hospitalized community-acquired pneumonia
    De Benedetto, Fernando
    Del Ponte, Adriana
    Grassi, Carlo
    MULTIDISCIPLINARY RESPIRATORY MEDICINE, 2010, 5 (06) : 422 - 431
  • [36] Another view on the prediction of outcomes in patients with community-acquired pneumonia
    Schuetz, P.
    Zimmerli, W.
    Mueller, B.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (04) : 992 - 993
  • [37] The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia
    Aliberti, S.
    Myers, J. A.
    Peyrani, P.
    Blasi, F.
    Menendez, R.
    Rossi, P.
    Cosentini, R.
    Lopardo, G.
    de Vedia, L.
    Ramirez, J. A.
    EUROPEAN RESPIRATORY JOURNAL, 2009, 33 (01) : 142 - 147
  • [38] How to assess survival prognosis in patients hospitalized for community-acquired pneumonia in 2024?
    Ramirez, Julio A.
    File, Thomas M.
    CURRENT OPINION IN CRITICAL CARE, 2024, 30 (05) : 399 - 405
  • [39] Risk factors for Clostridium difficile infection in hospitalized patients with community-acquired pneumonia
    Chalmers, James D.
    Akram, Ahsan R.
    Singanayagam, Aran
    Wilcox, Mark H.
    Hill, Adam T.
    JOURNAL OF INFECTION, 2016, 73 (01) : 45 - 53
  • [40] Clinical predictors of bacteremia in immunocompetent adult patients hospitalized for community-acquired pneumonia
    Fernando Saldias, P.
    Tomas Reyes, B.
    Josefina Saez, B.
    Carmen Rain, M.
    Pamela Illanes, C.
    Catalina Bricneo, V
    Orlando Diaz, P.
    REVISTA MEDICA DE CHILE, 2015, 143 (05) : 553 - 561